Literature DB >> 24123116

Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease.

Nancy A Pachana1, Sarah J Egan, Ken Laidlaw, Nadeeka Dissanayaka, Gerard J Byrne, Simone Brockman, Rodney Marsh, Sergio Starkstein.   

Abstract

A significant proportion of persons affected by Parkinson's disease (PD) are over age 65 years. Mental health issues are often less a focus of treatment in this population than physical manifestations of the illness. Anxiety or depression alone, as well as comorbid depression and anxiety, are underrecognized in patients with PD and are associated with deleterious effects on physical and interpersonal functioning, negatively impacting quality of life and well-being. We offer a brief overview of salient clinical points with respect to assessment and treatment approaches to enhance efficacy of the treatment of mental health symptoms in older adults with PD. Cognitive behavior therapy involves the patient learning to overcome behavioral avoidance associated with anxiety and challenge unhelpful negative cognitions. It is suggested that cognitive behavior therapy is an effective approach to treatment of anxiety and depression in PD and should be offered as a treatment to patients.
© 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; anxiety; cognitive behavioral therapy; depression; measurement

Mesh:

Year:  2013        PMID: 24123116     DOI: 10.1002/mds.25689

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  A practical approach to detection and treatment of depression in Parkinson disease and dementia.

Authors:  Zahra Goodarzi; Zahinoor Ismail
Journal:  Neurol Clin Pract       Date:  2017-04

Review 2.  Detecting depression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Zahra Goodarzi; Kelly J Mrklas; Derek J Roberts; Nathalie Jette; Tamara Pringsheim; Jayna Holroyd-Leduc
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

Review 3.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 4.  Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Authors:  Atami Sagna; Joseph J Gallo; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2014-04-01       Impact factor: 4.891

Review 5.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

6.  The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Authors:  Robert D Salazar; Asher M Le; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Parkinsonism Relat Disord       Date:  2017-01-24       Impact factor: 4.891

Review 7.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

Review 8.  Effect of Physical Activity on Depression in Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.

Authors:  Jianing Tian; Yujie Kang; Peifeng Liu; Hongyan Yu
Journal:  Int J Environ Res Public Health       Date:  2022-06-03       Impact factor: 4.614

9.  Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease.

Authors:  Davide L Vetrano; Maria S Pisciotta; Maria R Lo Monaco; Graziano Onder; Alice Laudisio; Vincenzo Brandi; Domenico La Carpia; Mauro Guglielmo; Antonio Nacchia; Domenico Fusco; Diego Ricciardi; Anna R Bentivoglio; Roberto Bernabei; Giuseppe Zuccalà
Journal:  J Neurol       Date:  2015-09-04       Impact factor: 4.849

10.  Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Peter A Silburn; David A Copland; George D Mellick; Gerard J Byrne
Journal:  Mov Disord Clin Pract       Date:  2015-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.